Jant Pharmacal

What Jant Pharmacal does

Jant Pharmacal Corporation is a privately held US specialty medical device distributor founded in 1986 and headquartered in Encino, California. The company develops, markets, and distributes point-of-care diagnostics and clinical laboratory analyzers, reagents, and quality control products to physicians' offices, clinics, hospitals, and reference laboratories across the United States. Its portfolio is organized into three divisions: Point-of-Care Diagnostics (CLIA-waived rapid tests marketed under its registered Accutest® and Accustrip® brands for cardiac, infectious disease, drugs of abuse, pregnancy, hypothyroid, colorectal, and urinalysis testing); Core Laboratory (CLIA-moderate and high-complexity analyzers and reagents from OEM partners including Beckman Coulter, Tosoh, HORIBA, Mindray, and Medonic, plus quality control products from Thermo Scientific MAS, Randox, and Quantimetrix, and Bolt/ThunderBolt chemiluminescent immunoassay platforms); and Molecular Testing (Research Use Only NGS, extraction, real-time PCR, and RUO/EUA COVID panels). The company also offers laboratory consultation services spanning financial feasibility assessment, turn-key lab setup, CLIA regulatory compliance, LCMS method development, and LIS integration.

Jant Pharmacal generates revenue primarily through hardware and consumable sales of distributed diagnostic instruments and reagents, complemented by recurring reagent/quality-control consumable pull-through (razor/blade economics on placed analyzers), OTC/home testing product sales (Flowflex, Healgen, OraQuick), and fee-based laboratory consulting. Go-to-market is direct: a toll-free sales line (800-676-5565), a transactional website with product catalogs and quote/contact forms, and email newsletters. The GTM motion targets two distinct buyer types: bottom-of-funnel direct sales to physicians' offices and clinics (for POC testing), and field/enterprise sales to hospital and reference labs (for full analyzer/reagent solutions), supported by ROI assessments and turn-key setup services that reduce buyer friction.

The company's core technology is not proprietary instrument development but rather curation and channel integration of CLIA-compliant diagnostic workflows: integrating CLIA-waived rapid tests with CLIA-moderate/high-complexity analyzers, reagents, QC controls, and bidirectional LIS interfaces (notably on the Bolt chemiluminescent analyzer). Brand equity in Accutest® and Accustrip® (registered trademarks since 1986) and ~40 years of distribution relationships with major IVD OEMs constitute the primary commercial assets. There is no disclosed external institutional investment, no parent company, no subsidiaries, and no public M&A activity in the source material.

Name

Jant Pharmacal

Legal name

Jant Pharmacal Corporation

Website

https://jantdx.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

11–50 employees

Short description

Jant Pharmacal is a US specialty distributor that markets Accutest® and Accustrip® point-of-care diagnostics and distributes clinical lab analyzers, reagents, and quality controls from major OEMs to physicians' offices, clinics, hospitals, and reference laboratories.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges) (HLAHAOAI)

Keywords

• Point-of-care diagnostics
• Clinical chemistry analyzers
• Immunoassay analyzers
• Hematology analyzers
• Molecular testing reagents

Headquarters

HQ city

Encino

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Point-of-Care Diagnostic Products: Sale of CLIA-waived rapid tests under Accutest® and Accustrip® brands for cardiac testing, colorectal cancer, drugs of abuse, hypothyroidism, infectious diseases, pregnancy & fertility, and urinalysis.
2. Laboratory Analyzers and Reagents: Sale and distribution of clinical chemistry, hematology, immunoassay, toxicology, and urinalysis systems and reagents from OEM partners including Beckman Coulter, Mindray, and HORIBA.
3. Quality Control Products: Distribution of QC/control products from Randox, Quantimetrix, and Thermo Scientific MAS for laboratory quality assurance.
4. Laboratory Consultation Services: Services including Financial Feasibility Assessment, Turn-Key Laboratory Setup, CLIA Regulatory Consultation, LCMS Method Development, and Laboratory Information System Integration.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Jant Pharmacal develops, markets, and distributes in vitro diagnostic products organized across three divisions: Point-of-Care Diagnostics (CLIA-waived rapid tests marketed under Accutest® and Accustrip® brands for cardiac, infectious disease, urinalysis, drugs of abuse, pregnancy, and colorectal cancer screening); Core Laboratory Analyzers and Reagents (clinical chemistry, immunoassay, hematology, toxicology, LCMS systems and reagents from OEM partners such as Beckman Coulter, Mindray, HORIBA, Tosoh, AB Sciex, Agilent, and Shimadzu); and Molecular Testing (RUO/EUA next-generation sequencing, extraction, real-time PCR). The company also provides laboratory consultation services including LCMS method development, CLIA regulatory compliance, financial feasibility assessments, and turn-key laboratory setup.

Product overview

Jant Pharmacal Corporation, founded in 1986 and headquartered in Encino, California, offers a comprehensive portfolio of medical diagnostics products organized across three main divisions: Point-of-Care Diagnostics (under Accutest® and Accustrip® brands), Core Laboratory Analyzers and Reagents (CLIA Moderate and High Complexity), and Molecular Testing (Research Use Only). The Point-of-Care division provides CLIA-waived rapid tests for cardiac markers (RAMP 200, RAMP Cardiovascular Markers), infectious diseases (HIV, RSV, H. pylori, COVID-19/Flu), urinalysis (Accutest UriScreen, Accutest Urine Reagent Strips, Accustrip URS Reader), drugs of abuse screening, pregnancy testing, and colorectal cancer screening. The Core Laboratory division encompasses clinical chemistry analyzers (Indiko Plus, Mindray BA-800M/BS-480, Beckman Coulter AU series, refurbished Olympus AU systems), immunoassay systems (Tosoh AIA-360/900/2000, FREND by NanoEntek, Bolt ELISA/CLIA, ThunderBolt), hematology analyzers (HORIBA ABX Micros/Pentra series, Medonic M-Series), and comprehensive quality controls (Randox, Quantimetrix, Thermo Scientific MAS). The Molecular Testing division supplies next-generation sequencing products, automated and manual extraction systems, real-time PCR instruments and panels, and specialized panels for respiratory, gastrointestinal, antibiotic resistance, pharmacogenomics, and COVID/EUA testing. Jant Pharmacal also provides laboratory consulting services including LCMS method development, CLIA regulatory compliance, financial feasibility assessments, and turn-key laboratory setup.

Differentiator

Problem solved

Functional benefit

Brands

• Accutest®: Registered trademark for point-of-care rapid test products
• Accustrip®

Products and services

• Accutest UriScreen Rapid point-of-care diagnostic test for urinary tract infection screening for use in physicians' offices, clinics, and laboratories.
• Accutest Urine Reagent Strips Semi-quantitative dipstick test strips for rapid urinalysis testing under the Accutest® brand.
• Accustrip URS Reader & Strips
• RAMP 200 Response Bio Cardiac Diagnostic System CLIA-moderate complexity cardiac diagnostic system for rapid NT-proBNP testing at point-of-care settings.
• RAMP Cardiovascular Markers
• RAMP RSV Test
• Accutest H. pylori Urease Test Rapid point-of-care test for detection of Helicobacter pylori infection using urease methodology.
• Flowflex RSV + Flu A/B + COVID Home Test 4-in-1 home test for simultaneous detection of RSV, Influenza A/B, and COVID-19 from nasal swab samples.
• Healgen Rapid Check COVID-19/Flu A&B Antigen OTC Test Over-the-counter rapid antigen test for simultaneous detection of COVID-19 and Influenza A and B.
• OraQuick HIV Self-Test
• RSV Antigen Rapid Test Kit Rapid antigen test for RSV detection.
• Indiko Plus Clinical & Specialty Chemistry Analyzer
• Mindray BA-800M Chemistry and Toxicology Analyzer
• Mindray BS-480 Chemistry and Toxicology Analyzer
• Beckman Coulter AU Reagents
• Refurbished AU480 Chemistry/Toxicology Analyzer
• Refurbished AU640 Chemistry/Toxicology Analyzer
• Refurbished AU680 Chemistry/Toxicology Analyzer
• Refurbished AU5800 Chemistry/Toxicology Analyzer
• Immunalysis ImmTox 270 Benchtop Analyzer
• Tosoh AIA-360 Automated Immunoassay Analyzer
• Tosoh AIA-900 Automated Immunoassay Analyzer
• Tosoh AIA-2000 Automated Immunoassay Analyzer
• Tosoh AIA Reagents (Immunology)
• FREND System by NanoEntek
• NanoEntek FREND Reagents (Immunology)
• The Bolt ELISA and CLIA Assay Chemiluminescent Analyzer Compact one-plate ELISA and CLIA processor with modular design combining pipette, washer, incubator, shaker, and reader for automated immunoassay processing; software integrates with most Laboratory Information Systems.
• ThunderBolt ELISA and Chemiluminescent Analyzer High-performance ELISA and chemiluminescence analyzer for clinical and research immunoassay applications.
• Horiba ABX Micros ESV 60 Vet Hematology Analyzer
• Horiba ABX Micros 60 Hematology Analyzer
• Horiba ABX Micros ES60 Hematology Analyzer
• Horiba ABX Pentra 60 C+ Hematology Analyzer
• Horiba ABX Pentra XL 80 Hematology Analyzer
• HORIBA Reagents (Chemistry & Hematology)
• Medonic M-Series Hematology Analyzer (Autoloader Sampling)
• Medonic M-Series Hematology System (Closed Vial)
• Medonic M-Series Hematology System (Open Vial)
• Randox Controls
• Quantimetrix Controls
• Thermo Scientific MAS Quality Controls
• Thermo Scientific MAS UA Controls Bi-level liquid ready-to-use urinalysis controls with improved room temperature storage, covering 10 dipstick tests plus Microalbumin, Creatinine and hCG.
• Thermo Scientific MAS Serum Tox Control Set Control set for monitoring semi-quantitative measurement of Benzodiazepine, Barbiturates, and Tricyclic Antidepressants in human serum, plasma, and urine.
• Next-Generation Sequencing Solutions
• Automated and Manual Extraction Systems
• Real-Time PCR Instruments and Panels
• RUO/EUA COVID Panels for RT-PCR
• LCMS Method Transfer & Validation
• System Specific Method Development and Installation
• CLIA Regulatory and Compliance Consultation
• Financial Feasibility Assessment
• Turn-Key Laboratory Setup
• Laboratory Information System Selection and Integration

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Twelve partnerships are on record, tiered core.

• Beckman CoultercoreTechnology or IntegrationDistribution partner for Beckman Coulter AU reagents (bar-coded and pour over formats) and Beckman Coulter AU series analyzers including AU400, AU480, AU640, AU680, and AU5800. Jant Pharmacal offers both new and refurbished Beckman Coulter analyzers along with the complete test menu reagents.
• AB SciexcoreTechnology or IntegrationSupplier of Liquid Chromatography/Mass Spectrometry (LCMS) analyzers for toxicology laboratories. Jant Pharmacal offers both new and refurbished AB Sciex LCMS systems along with method validation assistance and related standards/reagents.
• AgilentcoreTechnology or IntegrationSupplier of LCMS analyzers for toxicology labs. Jant Pharmacal offers Agilent LCMS systems (new or refurbished) with method validation support.
• ShimadzucoreTechnology or IntegrationSupplier of LCMS analyzers for toxicology laboratories. Jant Pharmacal offers Shimadzu LCMS systems with method development and installation services.
• Gold Standard Diagnostics (Eurofins Technologies)coreTechnology or IntegrationManufacturer of the BOLT ELISA and CLIA Assay Chemiluminescent Analyzer, a one-plate ELISA+CLIA processor. Eurofins Technologies' strategic partner Gold Standard Diagnostics manufactures this instrument which Jant Pharmacal distributes.
• Thermo Scientific MAScoreTechnology or IntegrationDistribution of Thermo Scientific MAS quality controls including UA Controls, Serum Tox Control Set, and related control products for laboratory quality assurance.
• TosohcoreTechnology or IntegrationDistribution of Tosoh AIA immunoassay analyzers (AIA-360, AIA-900, AIA-2000) and reagents for automated immunoassay testing in laboratory settings.
• NanoEntekcoreTechnology or IntegrationDistribution of NanoEntek FREND System and reagents for immunoassay testing applications.
• HORIBAcoreTechnology or IntegrationDistribution of HORIBA ABX hematology analyzers including Micros ESV 60, Micros 60, Micros ES60, Pentra 60 C+, and Pentra XL 80, along with HORIBA reagents for chemistry and hematology testing.
• MindraycoreTechnology or IntegrationDistribution of Mindray chemistry and toxicology analyzers including BA-800M and BS-480, along with compatible reagents.
• ImmunalysiscoreTechnology or IntegrationDistribution of Immunalysis ImmTox 270 benchtop analyzer for toxicology testing applications.
• CDS (Clinical Diagnostic Systems)coreTechnology or IntegrationManufacturer of Medonic M-Series Hematology Analyzers (Open Vial, Closed Vial, and Autoloader sampling systems) distributed by Jant Pharmacal.

Scale indicators2 records

Recent moves6 records

Expansion highlights3 records

Direct peers

• BTNX: Canadian rapid lateral-flow manufacturer (Rapid Response branded tests for drugs of abuse, infectious disease, cardiac markers); directly comparable to Accutest-branded POC tests with overlapping product menu and customer segments.
• Sekisui Diagnostics: Manufacturer of OSOM rapid immunoassay tests for physician office labs and clinics, plus clinical chemistry systems; competes head-to-head with Jant's Accutest line and CLIA-waived POC portfolio.
• Chembio Diagnostics: Smaller-scale US-listed rapid diagnostics developer focused on lateral-flow POCT (HIV, syphilis, COVID/Flu). Comparable in size and product focus to Jant's branded rapid-test business and faces the same competitive dynamics from scaled POCT players.
• Princeton BioMeditech: US rapid diagnostics manufacturer whose BioSign rapid tests compete directly with Accutest POC cards; sized similarly to Jant and operating in the same physician-office distribution model.
• QuidelOrtho: US-based rapid diagnostics leader (QuickVue, Sofia, Triage) serving physician offices, urgent care and laboratories with lateral-flow and immunoassay POCT — directly comparable to Jant's Accutest/Accustrip franchise and broader POC distribution business.

Emerging players

• SD Biosensor: Korean rapid diagnostics manufacturer growing its Standard Q/BIOCREDIT lateral-flow portfolio in the US through OTC retail and professional channels; overlaps with Jant's Accutest, Healgen, and Flowflex rapid-test franchises.

Broad incumbents

• Henry Schein: Major US distributor of medical, dental, and laboratory products to physician offices and clinics; competes for the same point-of-care and consumables wallet as Jant across the physician-office lab segment.
• McKesson Medical-Surgical: Largest US distributor of medical-surgical supplies to physician offices and laboratories; comparable wholesale/distribution model in the same physician-office channel that Jant Pharmacal serves.
• Beckman Coulter: Core OEM partner for the AU clinical chemistry series and DxH hematology analyzers Jant distributes; competes directly with Jant's bundled lab solutions via its own direct sales and service network in US hospitals and reference labs.
• Abbott Point of Care: i-STAT and Alinity systems dominate the CLIA-waived cardiac and chemistry POCT market served by Jant; a broad incumbent whose scale and existing hospital contracts set the pricing and competitive baseline against Jant's POC offering.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/JantPharmacalCo
• LinkedInlinkedin.com/company/jant-pharmacal-corporation

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jant Pharmacal